These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 19663129

  • 1. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M.
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [Abstract] [Full Text] [Related]

  • 2. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
    Eid NS, Noonan MJ, Chipps B, Parasuraman B, Miller CJ, O'Brien CD.
    Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
    [Abstract] [Full Text] [Related]

  • 3. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C.
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD.
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE, Bleecker ER, O'Dowd L, Miller CJ, Mezzanotte W.
    Allergy Asthma Proc; 2010 Sep; 31(1):49-59. PubMed ID: 20167145
    [Abstract] [Full Text] [Related]

  • 6. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
    Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
    [Abstract] [Full Text] [Related]

  • 7. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
    Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
    [Abstract] [Full Text] [Related]

  • 8. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 9. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 10. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Sep; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 13. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [Abstract] [Full Text] [Related]

  • 14. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 15. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H, Parasuraman B, Boggs R, Miller CJ, Leidy NK, O'Dowd L.
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [Abstract] [Full Text] [Related]

  • 16. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
    Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
    Drugs; 2008 Jun; 68(14):1975-2000. PubMed ID: 18778120
    [Abstract] [Full Text] [Related]

  • 18. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K.
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [Abstract] [Full Text] [Related]

  • 19. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma.
    Morice AH, Hochmuth L, Ekelund J, Thorén A, Puterman AS.
    Pulm Pharmacol Ther; 2008 Nov; 21(1):32-9. PubMed ID: 17118686
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
    Respiration; 2005 Nov; 72 Suppl 1():20-7. PubMed ID: 15915009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.